Enteric coated guar gum microspheres of ornidazole for colonic delivery

Current Nanoscience

Volumn 8, Issue 4, 2012, Pages 571-580

  Shukla, Raj Kumar ^a   Ramteke, Suman ^a   Trivedi, Piyush ^a   Tiwari, Akanksha ^a,b  

^a UNIVERSITY INSTITUTE OF TECHNOLOGY   (India)

^b M S UNIVERSITY OF BARODA   (India)

Author keywords

Bacterial culture; DSC; Enteric coating; Eudragit S100; Guar gum; Microspheres; Ornidazole; Rat cecal contents; XRD

Indexed keywords

BACTERIAL CULTURES; DSC; ENTERIC-COATING; EUDRAGIT; GUAR GUMS; ORNIDAZOLE; XRD;

COATINGS; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY; ENCAPSULATION; RATS; X RAY DIFFRACTION ANALYSIS;

MICROSPHERES;

EUDRAGIT; GUAR GUM; MICROSPHERE; ORNIDAZOLE;

ARTICLE; CONTROLLED STUDY; CROSS LINKING; DIFFERENTIAL SCANNING CALORIMETRY; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SOLUBILITY; ENCAPSULATION; IN VITRO STUDY; NONHUMAN; PARTICLE SIZE; PH; PRIORITY JOURNAL; RAT; X RAY DIFFRACTION;

BACTERIA (MICROORGANISMS); BACTEROIDES; CYAMOPSIS TETRAGONOLOBA; OVATUS; RATTUS;

EID: 84863886669     PISSN: 15734137     EISSN: 18756786     Source Type: Journal    
DOI: 10.2174/157341312801784186     Document Type: Article

References (45)

1. Maestrelli, F., Cirri, M.; Corti, G.; Mennini N.; Mura P. Development of enteric-coated calcium pectinate microspheres intended for colonic drug delivery. Eur. J. Pharm. Biopharm., 2008, 69, 508-518.
2. Rijnierse, A.; Nijkamp, F.P.; Kraneveld A.D. Mast cells and nerves tickle in the tummy implications for inflammatory bowel disease and irritable bowel syndrome. Pharmacol. Ther., 2007, 116, 207-235.
3. Yang, L.; Chu J.S.; Fix, JA. Colon-specific drug delivery: New approaches and in vitro/in vivo evaluation. Int. J. Pharm., 2002, 235, 1-15.
4. Friend, D.R.; Sellin, J. Drug delivery in advancing the treatment of inflammatory bowel disease. Adv. Drug Deliv. Rev., 2005, 57, 215-216.
5. Oosegi, T.; Onishi, H.; Machida, Y. Gastrointestinal distribution and absorption behavior of Eudragit-coated chitosan-prednisolone conjugate microspheres in rats with TNBS-induced colitis. Int. J. Pharm., 2008, 348, 80-88.
6. Yamamoto A.; Tozaki, H.; Okada, N.; Fujita, T. Colon-specific delivery of peptide drugs and anti-inflammatory drugs using chitosan capsules. S.T.P. Pharm. Sci., 2000, 10, 23-34.
7. Crcarevska, M. S, Dodov, M. G, Goracinova, K. Chitosan coated Ca-alginate microparticles loaded with budesonide for delivery to the inflamed colonic mucosa. Eur. J. Pharm. Biopharm., 2008, 68, 565-578.
8. Mastiholimath, V.S.; Dandagi, P.M.; Jain, S.S.; Gadad. AP.; Kulkarni, A.R. (2007). Time and pH dependent colon specific, pulsative delivery of theophylline for nocturnal asthma. Int. J. Pharm., 2007, 328, 49-56.
9. Reynolds, J.E.F. Martindale-The Extra Pharmacopoeia (Pharmaceutical Press, London). 1996, 380.
10. Weissman, S.; Salata, R. Nelson textbook of pediatrics. Philadelphia W.B. Saunders Company, 2000, 1035-1036.
11. Mc Coy, J.J.; Mann, B.J.; Petri, WA. Adherence and cytotoxicity of Entamoeba histolytica or how lectins let parasites stick around. Infection Immunity, 1994, 62, 304-305.
12. Harry, G.B. Ornidazole comprehensive profile. In: Profiles of drug substances, excipients and related methodology. Elsevier, 2003, 30, 165.
13. Leopold, C.S.; Eikeler, D. Eudragit® E as coating material for the pH controlled drug release in the topical treatment of inflammatory bowel disease (IBD). J. Drug Target, 1998, 6, 85-94.
14. Zou, M.; Wang Y.; Xu C.; Cheng G.; Ren, J.; Wu, G. Wax-matrix tablet for time-dependent colon-specific delivery system of Sophora flavescens Aiton: Preparation and in vivo evaluation. Drug Dev. Ind. Pharm., 2009, 35, 224-233.
15. Lucinda-Silva, R.M.; Salgado, H.R.N.; Evangelista, R.C. Alginate-chitosan systems: In vitro controlled release of triamcinolone and in vivo gastrointestinal transit. Carbohydr. Polym., 2010, 81, 260-268.
16. Rahman, Z.; Kohli, K.; Zhang, S.Q.; Khar, R.K.; Ali, M.; Charoo, N.A.; Tauseef, M.; Shamsher, A.A.; Mohammed, N.N.; Repka, M.A. In vivo evaluation in rats of colon-specific microspheres containing 5-fluorouracil. J. Pharm. Pharmacol., 2008, 60, 615-623.
17. Shukla, R. K.; Tiwari, A. Carbohydrate molecules; An expanding horizon in drug delivery and biomedicine. Crit. Rev. Therap. Drug Carrier Sys., 2011, 28, 255-292.
18. Tiwari, A.; Ramteke, S.; Dahima, R.; Shukla. R.K. Preparation and Characterization of Satranidazole Loaded Calcium Pectinate Microbeads for Colon Specific Delivery; Application of Response Surface Methodology. Curr. Nanosci., 2011, 7, 608-615.
19. Shukla, R.K.; Tiwari, A.K. Carbohydrate polymers; Applications and recent advances in delivering drugs to the colon. Carbohydr. Polym., 2012, 88(2), 399-416.
20. Shukla, R.K.; Trivedi, P.; Ramteke, S.; Tiwari, A. Preparation and characterization of cross-linked guar gum microspheres: optimization using factorial design. Chem. Pharm. Bull., 2011, 59, 185-190.
21. Zhi-gang, F.; Ping, P.; Zhi-qiang, Y.; Ya-gen, C.; Jian-kang, Z.; Miao, W.; Xue-nong, Z.; Qiang, Z. Two Novel Freeze-Dried pH-Sensitive Cyclosporine A Nanoparticles: Preparation, in vitro Drug Release, and in vivo Absorption Enhancement Effects. Curr. Nanosci., 2009, 5, 449-456.
22. Satish, R.; Sanjiv, R. Study of polymorphic transformation of ornidazole drug by differential scanning calorimetry and other complementary techniques. Acta Pol. Pharm. Drug Res., 2008, 65, 409-413.
23. Baileyr, W.; Oxforda, E. A quantitative study of the production of dextran from sucrose by rumen strains of Streptococcus Bovisj. Gen. Microbiol. 1958, 19, 130-145.
24. 2 concentration on the growth and exopolysaccharide production of Bifidobacterium longum cultivated under anaerobic conditions. J. Biosci. Bioeng. 2009, 107, 535-537.
25. Joel Dain, A.; Neal, A.L.; Seeley, H.W. The effect of carbon dioxide on polysaccharide production by streptococcus bovis. J. Bacteriol., 1956, 72, 209-213.
26. Hadjiioannou, T.P.; Christian, G.D.; Koupparis, M.A.; Macheras, P.E. Quantitative Calculations in Pharmaceutical Practice and Research. VCH Publishers Inc New York, 1993, 345-348.
27. Bourne, D.W.A. Pharmacokinetics: In: Banker GS, Rhodes CT Modern Pharmaceutics, 4th ed. Marcel Dekker Inc New York. 2002, 67-92.
28. Higuchi, T. Mechanism of sustained action medication Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J. Pharm. Sci., 1963, 52, 1145-1149.
29. Hixson, A.W.; Crowell, J.H. Dependence of reaction velocity upon surface and agitation (I) theoretical consideration. Ind. Eng, Chem., 1931, 23, 923-931.
30. Korsmeyer, R.W.; Gurny, R.; Doelker, E.; Buri, P.; Peppas, N.A. Mechanisms of solute release from porous hydrophilic polymers. Int. J. Pharm., 1983, 15, 25-35.
31. Siepmann J.; Peppas NA. Mathematical modeling of controlled drug delivery. Adv. Drug Deliv. Rev., 2001, 48, 137-139.
32. Pasparakis, G.; Bouropoulos N. Swelling studies and in vitro release of verapamil from calcium alginate and calcium alginate-chitosan beads. Int. J. Pharm., 2006, 323, 34-42.
33. Rama Prasad, Y.V.; Krishnaiah. Y.S.R.; Satyanarayana, S. In vitro evaluation of guar gum as a carrier for colon specific drug delivery. J. Control. Release, 1998, 51, 281-287.
34. Krishnaiah, Y.S.R.; Satyanarayana, V.; Dinesh Kumar, B.; Karthikeyan, R.S. In vitro drug release studies on guar gum based colon targeted oral delivery systems of 5-Fluorouracil. Eur. J. Pharm. Sci., 2002, 16, 185-192.
35. Salyers, A.A.; Palmer, J.K.; Wilkins, T.D. Degradation of polysaccharides by intestinal bacterial enzymes. Am. J. Clin. Nutr., 1978, 31, 128-130.
36. Ashford, M.; Fell, J. T, Attwood, D.; Sharma, H.; Woodhead P. An in vivo investigation into the suitability of pH-dependent polymers for colonic targeting. Int. J. Pharm., 1993, 95, 193-199.
37. Rubinstein, A. Microbially controlled drug delivery to the colon. Biopharm. Drug Dispos. 1990, 11, 465-475.
38. Bayliss, C.E., Houston, A.P. Degradation of guar gum by faecal bacteria. Appl. Environ. Microbiol., 1986, 48, 626-632.
39. Tomolin, J.; Taylor, J.S.; Read, N.W. The effect of mixed faecal bacteria on a selection of viscous polysaccharide in vitro. Nutr. Rep. Int., 1989, 39, 121-135.
40. Macfarlane, G.T.; Hay, S.; Macfarlane, S.; Gibson, G.R. Effect of different carbohydrates on growth polysaccharidases and glycosidase production of Bacteroides ovatus in batch and continuous culture. J. Appl. Bacteriol., 1990, 68, 179-187.
41. Tomlin, B.J.; Read, N.W.; Edwards, C.A.; Duerden, B.I. The degradation of guar gum by fecal incubation system. Brit. J. Nutrn., 1986, 55, 481-86.
42. Rama Prasad, Y.V.; Krishnaiah, Y.S.R.; Satyanarayana, S. In vitro evaluation of guar gum as a carrier for colon-specific drug delivery. J. Control. Release, 1998, 51, 281-287.
43. Singh, B.; Chauhan, N. Modification of psyllium polysaccharides for use in oral insulin delivery. Food Hydrocolloids., 2009, 23, 928-935.
44. Sande, S.A. Pectin-based oral drug delivery to the colon. Expert Opin. Drug Deliv., 2005, 2, 441-450.
45. Rubinstein, A.; Radai, R. In vitro and in vivo Analysis of colon specificity of calcium pectinate formulations. Eur. J. Pharm. Biopharm., 1995, 41, 291-295.